Sitonce
Country: US
Show exams for United States Hong Kong
Sign in

Ointment Versus Cream

Updated 6 min read
Key takeaway

Creams and ointments are semisolid dosage forms whose vehicles can differ in composition, texture, drug release, and skin effects.

More key points
  • Match the prescribed product and dosage form; equal ingredient strength does not make them automatically interchangeable.
On this page8 sections
  1. The vehicle has a pharmaceutical role
  2. Occlusion describes a property, not a universal ranking
  3. Drug strength and product performance are different
  4. Dosage form does not fully specify the route
  5. Packaging affects use and identification
  6. Appearance can reveal a quality concern
  7. Prevent cream-and-ointment selection errors
  8. Reading a PTCE question

A cream and an ointment may contain the same active drug and display the same strength, yet still be different products. The vehicle surrounding the drug affects how the preparation spreads, remains at the application site, and releases its ingredient. The dosage form is therefore part of product identity.

A useful introductory pattern is that many creams are less greasy and many petrolatum-based ointments are more greasy and occlusive. But those descriptions are tendencies, not complete definitions. FDA's current guidance emphasizes that a dosage-form name alone does not reveal all of a topical product's physical and structural properties.

The vehicle has a pharmaceutical role

The vehicle is the base or delivery medium in which the active ingredient is dissolved or dispersed. It influences the product's consistency, stability, and interaction with the application site. It may also contain ingredients needed to maintain the formulation.

A cream may contain oil and water organized as an emulsion, but FDA notes that some products called creams have other structures. Ointments can have a hydrocarbon base, an emulsion structure, or a polyethylene glycol base, among other possibilities. Avoid memorizing one fixed oil-to-water percentage as a universal rule.

This variation explains why product labeling and formulation information matter. Looking at a white semisolid in a tube does not establish its composition. A pharmacy technician should select the specified product rather than infer its identity from color, thickness, or how familiar the package looks.

Occlusion describes a property, not a universal ranking

An occlusive preparation forms a barrier that reduces water loss from the covered skin. Petrolatum-based ointments commonly have this property and may remain at the site for a relatively long time. That can affect the local environment and drug delivery.

It does not follow that every ointment is stronger or better than every cream. Drug identity, formulation, application site, skin condition, and instructions all matter. A broad statement that ointments always penetrate more would overlook differences between products.

Clinical selection belongs with the prescriber or pharmacist. The technician's role is to preserve the dosage form in the order and identify a mismatch. A patient's request for a less greasy product may be reasonable, but changing the vehicle can require a professional decision and an authorized prescription change.

Drug strength and product performance are different

The strength on a topical label describes the amount of active ingredient according to the product's labeling. It does not fully describe how that ingredient is released from the vehicle or reaches the intended site. Equal labeled concentration does not prove equal clinical performance across different formulations.

FDA evaluates relevant physical and structural properties when considering generic topical products. Properties such as particle size, the organization of phases, and flow behavior can affect product performance. These are reasons why a cream-to-ointment change is not just a packaging preference.

For an exam, distinguish the arithmetic meaning of concentration from therapeutic equivalence. A correct strength match is necessary in product selection, but it is only one part of the match. The drug, dosage form, route, and authorized product selection also need to agree.

Dosage form does not fully specify the route

Many creams and ointments are applied to skin, but semisolid products can be designed for other sites. An ophthalmic ointment is intended for the eye and must meet the requirements for that use. A skin ointment is not made suitable for the eye by having the same active ingredient.

Likewise, a product intended for a particular mucosal site may have instructions and an applicator that differ from a general skin product. Read the full label and order. The broad word topical does not authorize application to every external or mucosal surface.

A technician should stop when the selected product's route conflicts with the directions. Do not resolve the mismatch by adding an auxiliary label that makes the wrong product appear suitable. The pharmacist must clarify the order and approve the correct product.

Packaging affects use and identification

Creams and ointments may be supplied in tubes, jars, pumps, or other containers. Package size and delivery system are part of the dispensing check. A pump may have product-specific instructions that do not apply to a tube, even when the active ingredient is familiar.

The package also helps protect the formulation and carries important information such as the lot and expiration. Follow storage and handling instructions. Do not transfer a product into a different container for convenience unless the authorized pharmacy procedure addresses the suitability, labeling, and dating.

At pickup, a patient may compare the new container with a previous one. A changed package does not automatically mean a changed medicine, but it is a useful prompt to verify the exact product and connect the patient with the pharmacist if the formulation or use instructions differ.

Appearance can reveal a quality concern

Unexpected separation, unusual lumps, a changed odor, or damaged packaging may justify holding the product for pharmacist review. These observations do not identify the cause by themselves. Storage conditions, product-specific normal appearance, and manufacturer information all need consideration.

Do not instruct a patient to fix an unusual product by stirring, warming, diluting, or mixing it with another cream. Those actions can change the formulation or introduce contamination. The pharmacist can assess whether the product is acceptable and whether the manufacturer or supplier should be contacted.

Some products have specific handling instructions, and a technician may communicate authorized factual information from the label. Clinical questions about a reaction, worsening skin problem, or where to apply the medicine should be referred to the pharmacist.

Prevent cream-and-ointment selection errors

Products with the same drug and strength may sit beside each other in different dosage forms. Read the complete description on the order and package. A familiar drug name can draw attention away from the smaller dosage-form wording.

Barcode verification can support selection, but the technician must scan the actual package being used and respond to mismatches. A successful scan against the wrong entered product does not fix an order-entry error. The original order and final product still require the appropriate review.

If the prescribed ointment is unavailable and a cream is in stock, hold the substitution question for the pharmacist. Availability, coverage, and patient preference do not independently authorize a technician to change dosage forms. Preserve the concern so it is resolved before dispensing.

Reading a PTCE question

A question may ask which preparation is typically greasy and occlusive. A petrolatum-based ointment is a useful example. Another may ask whether a cream can replace an ointment at the same strength; the safe answer recognizes that dosage form and authorization matter.

Read for words such as always, identical, and automatically. Topical formulations vary, and simple texture rules have limits. FDA's guidance explains why product structure must sometimes be examined rather than inferred from the name.

The practical distinction is that cream and ointment identify different formulation categories, while the exact product determines its properties and use. Match the prescribed dosage form, keep the route clear, and refer formulation changes or clinical questions to the pharmacist.

Common questions

Are all ointments oil-only products?

No. Ointment formulations vary, including hydrocarbon, emulsion, and polyethylene glycol bases. The dosage-form name does not fully define composition.

Can a cream replace an ointment with the same drug strength?

Not automatically. The pharmacist must assess the authorized product and any required prescription or substitution decision.

Can a skin ointment be used in the eye if the ingredient matches?

No. Route-specific formulation and quality requirements matter. A technician must not substitute a skin product for an ophthalmic product.